Pictet Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95M | Sell |
69,620
-2,836
| -4% | -$324K | 0.01% | 701 |
|
|
2025
Q1 | $7.79M | Sell |
72,456
-6,670
| -8% | -$717K | 0.01% | 716 |
|
|
2024
Q4 | $8.48M | Buy |
79,126
+1,640
| +2% | +$176K | 0.01% | 708 |
|
|
2024
Q3 | $7.55M | Buy |
77,486
+9,116
| +13% | +$888K | 0.01% | 725 |
|
|
2024
Q2 | $5.76M | Sell |
68,370
-55,675
| -45% | -$4.69M | 0.01% | 759 |
|
|
2024
Q1 | $8.96M | Sell |
124,045
-5,502
| -4% | -$397K | 0.01% | 660 |
|
|
2023
Q4 | $9.25M | Buy |
129,547
+6,744
| +5% | +$482K | 0.01% | 659 |
|
|
2023
Q3 | $7.36M | Buy |
+122,803
| New | +$7.36M | 0.01% | 682 |
|